MIT Sloan BioInnovations 2008

What are the most powerful emerging technologies and innovations in biotechnology—and what are the key challenges the industry faces? Senior management, investors, and leading academics from the Bay State biotechnology community convene for this big day of idea exchanging and discussion brought to you by MIT’s Sloan School of Management. Xconomy editor in chief Bob Buderi will be moderating The 1st $10 Million—Going from Bench To Bedside, a panel focusing on “exploring the pathways and pitfalls to commercialization of technology in the life sciences.”